75.75 0.21 (0.28%) | 04-26 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 102.15 | 1-year : | 137.18 |
Resists | First : | 87.46 | Second : | 117.44 |
Pivot price | 74.09 | |||
Supports | First : | 38.95 | Second : | 32.4 |
MAs | MA(5) : | 74.4 | MA(20) : | 83.33 |
MA(100) : | 114.61 | MA(250) : | 112.73 | |
MACD | MACD : | -11 | Signal : | -12.4 |
%K %D | K(14,3) : | 52.7 | D(3) : | 50.4 |
RSI | RSI(14): 39 | |||
52-week | High : | 132 | Low : | 38.95 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ GL ] has closed below upper band by 47.7%. Bollinger Bands are 318.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 15 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 77.04 - 77.4 | 77.4 - 77.74 |
Low: | 72.86 - 73.27 | 73.27 - 73.66 |
Close: | 75.07 - 75.72 | 75.72 - 76.34 |
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Fri, 26 Apr 2024
Labaton Keller Sucharow LLP is Investigating Claims against Globe Life Inc. and Encourages Investors to Contact the ... - AccessWire
Fri, 26 Apr 2024
Globe Life director Steven Johnson purchases $100k in company stock - Investing.com
Fri, 26 Apr 2024
Globe Life Under Fire: DOJ Probe and Short-Seller Cast Shadow on Insurer - Hagens Berman - GlobeNewswire
Thu, 25 Apr 2024
Globe Life Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Wed, 24 Apr 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globe Life Inc. - GL - Barron's
Wed, 24 Apr 2024
Globe Life First Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Financial Services
|
|
Industry:
Insurance - Life
|
|
Shares Out | 94 (M) |
Shares Float | 91 (M) |
Held by Insiders | 2.1 (%) |
Held by Institutions | 83.4 (%) |
Shares Short | 2,750 (K) |
Shares Short P.Month | 1,180 (K) |
EPS | 10.06 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 47.84 |
Profit Margin | 17.8 % |
Operating Margin | 25.6 % |
Return on Assets (ttm) | 3 % |
Return on Equity (ttm) | 23 % |
Qtrly Rev. Growth | 6 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 57.95 |
EBITDA (p.s.) | 14.03 |
Qtrly Earnings Growth | 16.7 % |
Operating Cash Flow | 1,480 (M) |
Levered Free Cash Flow | 1,180 (M) |
PE Ratio | 7.52 |
PEG Ratio | 0.3 |
Price to Book value | 1.58 |
Price to Sales | 1.3 |
Price to Cash Flow | 4.81 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |